Skip to content

M. Kirkpatrick

3 papers in the library · 303 citations · publishing 2011-2014

Papers

Sort Most recent Most cited

Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans

Psychoneuroendocrinology April 19, 2014 M. Kirkpatrick, Sunday M. Francis, Royce Lee et al. 106 citations

MDMA (±3,4-methylenedioxymethamphetamine, ‘ecstasy’) is reportedly used recreationally because it increases feelings of sociability and interpersonal closeness. Prior work suggests that the pro-social effects of MDMA may be mediated by release of oxytocin. A direct examination of plasma levels of oxytocin after acute doses of oxytocin and MDMA, in the same individuals, would provide further...

MDMA effects consistent across laboratories

Psychopharmacology March 15, 2014 M. Kirkpatrick, Matthew J. Baggott, John Mendelson et al. 78 citations

Several laboratories have conducted placebo-controlled drug challenge studies with 3,4-methylenedioxymethamphetamine (MDMA), providing a unique source of data to examine the reliability of the acute effects of the drug across subject samples and settings. We examined the subjective and physiological responses to the drug across three different laboratories and investigated the influence of...

A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans

Psychopharmacology June 30, 2011 M. Kirkpatrick, Erik W. Gunderson, Audrey Y. Perez et al. 119 citations

Despite their chemical similarities, methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) produce differing neurochemical and behavioral responses in animals. In humans, individual studies of methamphetamine and MDMA indicate that the drugs engender overlapping and divergent effects; there are only limited data comparing the two drugs in the same individuals. This study examined the...